Figure 3. PHD1 regulates phosphorylation of H3T3 during prometaphase.
(A) Schematic model of the role of PP1-RepoMan during prometaphase. (B) HeLa cells were transfected with siControl, or siRNA RepoMan. Cells were arrested in prometaphase with nocodazole 100 ng/mL for 16 hr and released from the arrest for 1 hr in normal media before fixation and stained with pH3T3 and DAPI. (C) Cells were treated as in (B) and harvested for western blot analysis. (D) Asynchronous or prometaphase-arrested HeLa cells were treated with FG4592 50 µM for 2 hr or DMSO. In case of mitotic cells, they were treated 1 hr before the release and during the release for another hour. Cells were lysed and subject to western blot. (E) Asynchronous or prometaphase arrested HeLa cells were treated with 100 µM fumarate for 1 hr. In case of mitotic cells, they were treated for 1 hr during the release. Cells were lysed and subject to western blot. (F) Immunofluorescence images of HeLa cells arrested in prometaphase. HeLa cells were transfected with siControl, siPHD1, siPHD2 (as in B). Prometaphase-arrested cells were released for 1 hr before fixation. Image scale bars represent 5 µm. (G) Graph displays the normalised pH3T3 intensity of total cells per condition from 3 independent experiments (n = 48 si control, n = 62 si PHD1, n = 47 siPHD2). pH3T3 intensity of each condition (siPHD1 and siPHD2) was normalised to the intensity values of pH3T3 in the siControl. The average of 3 independent experiments is shown. Unpair t-test ****p<0.0001, sicontrol vs siPHD1 and siPHD1 vs siPHD2; n.s, sicontrol vs siPHD2 p = 0.8963. (H) Western blot analysis of HeLa cells treated as in (F) and including asynchronous cells transfected with the control siRNA.

